PA Consulting's sustainability experts, Sofie Brøndum Christensen and Line Fryd Hofmansen, discuss how to succeed in transforming to a circular business model.
PA Consulting life sciences expert Nick Warrington and PA IoT and connected devices expert Charley Henderson explain that direct-to-cloud solutions should be considered in the development of connected medical devices.
Mike Haynes and Sophie Riegel, PA Consulting agile experts, and PA life sciences expert Haider Abbasi explain how medtech firms can leverage agile methodologies to achieve disruptive innovation.
PA Consulting’s medical device Human Factors experts, Philip Lance and Charlotte Redden, discuss how testing medical devices on target users in their own homes has brought about challenges as well as unexpected benefits due to COVID-19.
PA Consulting medtech experts Hilde Viroux and Hans Mische outline steps life sciences companies must take to comply with the new EU Regulation on In Vitro Diagnostic Devices that will take effect May 2022.
Alexandra Hadschieff and Evan Nelson, life sciences and medical device experts at PA Consulting, highlight 3 questions that health and life sciences organizations must answer before starting a Software as a Medical Device project.
PA Consulting’s healthcare expert, Valerie Phillips, and life sciences expert, Simon Bates, evaluate the digital health trends triggered by COVID-19 that are likely to continue in 2021.
PA Consulting medtech and life sciences experts Anna Ronning and Hilde Viroux explain how life sciences companies can develop at-home monitoring products that deliver actionable data.
PA Consulting medtech and life sciences experts Anna Ronning and Hilde Viroux discuss the regulatory compliance landscape for at-home monitoring devices.
Tyler Reynolds and Nadeem Fazal, health and life sciences experts at PA Consulting, share three steps that life sciences companies can take to run virtual clinical trials.
Hilde Viroux, medtech expert at PA Consulting, discusses the postponed EU Medical Devices Regulation and explains that manufacturers can use the delay to assess readiness and close gaps.
Phil Seeney, a drug delivery specialist at PA Consulting, looks at the arguments in favour of creating more sustainable inhalers, and examines potential strategies to accomplish it.
